title: Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
abstract: When caring for patients with multiple myeloma, questions often arise about the role and timing of autologous hematopoietic stem cell transplantation. As a complement to the other articles in this supplement, as well as to ensure that readers are provided with the insight needed to feel comfortable speaking to patients and other practitioners about this topic, the authors address eight frequently asked questions about common decision points in the process of autologous hematopoietic stem cell transplantation as a treatment for patients with multiple myeloma.
authors.affiliation: Abramson Cancer Center, University of Pennsylvania, Philadelphia.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Mangan
authors.forename: Charise L
authors.initials: CL
authors.lastname: Gleason
authors.forename: Teresa
authors.initials: T
authors.lastname: Miceli
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D016879:Salvage Therapy; D014182:Transplantation, Autologous